The major goal of the Protein Chemistry Resource is to provide sequence information of isolated proteins in low abundance at the Cancer Center of Cold Spring Harbor Laboratory. Sequence information is used to isolate genes or identify the genes in the database. Another goal is to analyze post-transcriptional modification of proteins to study protein function, protein-protein interaction and protein-nucleic acid interaction in cancer research. The Resource provides: protein sequence analysis by in-gel digestion, HPLC peptide mapping and automated Edman degradation N-terminal sequencing of protein blotted on PVDF membrane post-translational modification analysis by MALDI-TOF-mass spectrometry and HPLC peptide mapping followed by automated Edman degradation epitope mapping by using mass spectrometry, HPLC and peptide sequencer molecular weight determination of peptides, proteins, and other molecules mass spectrometry sequencing y LCQ deca electrospray mass spectrometry including post-translation modification site analysis Since there are so many proteins isolated with biological significance in all areas of molecular biology, genetics, and cell biology at the Cancer Center, the Protein Chemistry Shared Resource is used by a large number of the Cancer Center at Cold Spring Harbor Laboratory

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA045508-14
Application #
6348964
Study Section
Project Start
2000-09-08
Project End
2001-07-31
Budget Start
Budget End
Support Year
14
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Cold Spring Harbor Laboratory
Department
Type
DUNS #
065968786
City
Cold Spring Harbor
State
NY
Country
United States
Zip Code
11724
Cheng, Derek; Tuveson, David (2018) Kras in Organoids. Cold Spring Harb Perspect Med 8:
Albrengues, Jean; Shields, Mario A; Ng, David et al. (2018) Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science 361:
Cook, Natalie; Basu, Bristi; Smith, Donna-Michelle et al. (2018) A phase I trial of the ?-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma. Br J Cancer 118:793-801
Melnikov, Sergey V; Rivera, Keith D; Ostapenko, Denis et al. (2018) Error-prone protein synthesis in parasites with the smallest eukaryotic genome. Proc Natl Acad Sci U S A 115:E6245-E6253
Krishnan, Navasona; Bonham, Christopher A; Rus, Ioana A et al. (2018) Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development. Nat Commun 9:283
Pommier, Arnaud; Anaparthy, Naishitha; Memos, Nicoletta et al. (2018) Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science 360:
Krishnan, Navasona; Felice, Christy; Rivera, Keith et al. (2018) DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson's disease. Genes Dev 32:944-952
Tiriac, Herve; Bucobo, Juan Carlos; Tzimas, Demetrios et al. (2018) Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment. Gastrointest Endosc 87:1474-1480
Nattestad, Maria; Goodwin, Sara; Ng, Karen et al. (2018) Complex rearrangements and oncogene amplifications revealed by long-read DNA and RNA sequencing of a breast cancer cell line. Genome Res 28:1126-1135
Connell, Claire M; Raby, Sophie E M; Beh, Ian et al. (2018) Cancer Immunotherapy Trials Underutilize Immune Response Monitoring. Oncologist 23:116-117

Showing the most recent 10 out of 380 publications